✦ LIBER ✦

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

✍ Scribed by Devineni, Damayanthi; Curtin, Christopher R.; Polidori, David; Gutierrez, Maria J.; Murphy, Joseph; Rusch, Sarah; Rothenberg, Paul L.

Book ID: 121689104
Publisher: Sage Publications
Year: 2013
Tongue: English
Weight: 605 KB
Volume: 53
Category: Article
ISSN: 0091-2700
DOI: 10.1002/jcph.88

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium–glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus

✍ S. Kasichayanula; M. Chang; M. Hasegawa; X. Liu; N. Yamahira; F. P. LaCreta; Y. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

Evaluation of vulvovaginal symptoms and

Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor

✍ Nyirjesy, Paul; Zhao, Yue; Ways, Kirk; Usiskin, Keith 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 129 KB

Canagliflozin (CANA), a Sodium Glucose C

Canagliflozin (CANA), a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor, Improves Glycemia and is Well Tolerated in Type 2 Diabetes Mellitus (T2DM) Subjects With Moderate Renal Impairment

✍ Yale, Jean-Francois; Bakris, George; Xi, Liwen; Figueroa, Kate; Wajs, Ewa; Usisk 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 79 KB

Clinical Pharmacokinetics and Pharmacody

Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2

✍ Kasichayanula, Sreeneeranj; Liu, Xiaoni; LaCreta, Frank; Griffen, Steven C.; Bou 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 522 KB

Effects of Hydrochlorothiazide on the Ph

Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants

✍ Devineni, Damayanthi; Vaccaro, Nicole; Polidori, David; Rusch, Sarah; Wajs, Ewa 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Canagliflozin, a sodium glucose co-trans

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes

✍ Polidori, David; Mari, Andrea; Ferrannini, Ele 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 404 KB